- This event has passed.
Dr. Michelle Papka: On Emerging Non-Invasive Alzheimer’s Treatments
February 7 @ 10:00 am - 11:00 am PST
Free
This Live Talk is produced by Being Patient with support provided by Cognito Therapeutics.
Researchers and technology companies are looking into whether non-invasive electromagnetic, visual, and auditory stimulation can treat Alzheimer’s disease. But what do we know now about these emerging non-drug interventions and what they can do for the brain?
On Friday, February 7th, at 10 a.m. PT/1 p.m. ET, Dr. Michelle Papka, Founder and President of the Cognitive and Research Center of New Jersey (CRCNJ), will join Being Patient Live Talks to discuss emerging technology-assisted noninvasive interventions for Alzheimer’s disease. These include treatments like the SPECTRIS AD, which causes gamma wave activity with noninvasive visual and auditory stimulation.
Papka, a neuropsychologist, psychotherapist, and researcher, has over 30 years of combined experience specializing in aging, Alzheimer’s disease, and dementia. For over 15 years, she has also served as the Principal Investigator on industry-sponsored clinical trials for Alzheimer’s disease and age-related cognitive impairment. She is an active public speaker, invited editor, grant reviewer, consultant, and committee member of multiple specialized organizations and publications in aging and Alzheimer’s Disease. Papka is also the author and creator of “Memory Matters,” a monthly Q & A column about cognitive aging published in the NJ Star Ledger.
After working as a neuropsychologist in academia, Papka founded her private clinical practice in 2001 and the CRCNJ in 2009. She presides over the flagship site in Springfield, NJ, and the newer site in Ridgewood, NJ. Pinnacle Clinical Research recently acquired the CRCNJ. Papka is now the scientific director of CNS for the Pinnacle Network and a Key Opinion Leader Consultant to CNS at Summit Clinical Research, a related entity.
RSVP to the live talk to learn her perspective on non-invasive interventions for Alzheimer’s disease and what the future may hold for these treatments.
Have you read about the Tel Aviv University research wit using HBOT to help clear Amyloid Plaque?
Hi Nigel, thank you for being here. Our team is familiar with this research. Non-pharmaceutical interventions are continuing to be an important part of the conversation for treating Alzheimer’s and TBIs.
Looking forward to alternate treatments. Not medication treatments.
Hi Donna, thank you for being here. We’re looking forward to having you join us for our Live Talk with Dr. Michelle Papka on February 7th!
After 4 months I had an adverse event which was a focal seizure that required hospitalization, and which lasted for four days after stopping use of the machine. Their neurologist at the hospital noted that another person had come in with similar side effects.
Question for Dr. Papka: Is this alternative treatment (gamma rays etc) complementary to other treatments/ drugs like Leqembi? IE. Can you do both at same time? thx
Hi Rob, thank you for reaching out. I have passed this on to our Live Talks producer who will bring this up with Dr. Papka this coming Friday, February 7th. Looking forward to having you join us!
Look forward to it. My husband has early onset Alzheimer’s.
Am I registered?
Thanks Edith— I’ll see you at the Live Talk on Friday! I just double-checked the RSVP’s and you are indeed registered, so you are all set. You should get a reminder email from me the day of the talk!
Looking forward to learning alternative treatments other than medications..the medications are tricky. My husband has early Alzheimers.
I’d love to hear this. I can’t make r re his time though. Will you be recording this?
Thanks Donna! I’m glad you’re looking forward to it and will see you there tomorrow!
Hi Donna, we hope you enjoyed our Live Talk with Dr. Michelle Papka! Feel free to reference the full Live Talk on our YouTube channel here: https://www.youtube.com/watch?v=kA2thu9ZugE – Take care.